Wang et al. showed that cetuximab inhibits tumor-induced angiogenesis in vitro and in vivo by significantly downregulating HIF-1α and Notch1, resulting in reduced angiogenesis and tumor shrinkage [55]. The gene discussed is HIF1A; the disease is neoplasm.